HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

curcumin; coenzyme q10

WITHDRAWN · PHASE1, PHASE2 · Myelodysplastic Syndrome

No funding

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.